Pathstone Holdings’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.28M Sell
90,011
-903
-1% -$79K 0.02% 475
2026
Q1
$7.75M Sell
90,914
-2,501
-3% -$223K 0.03% 423
2025
Q4
$7.38M Buy
93,415
+9,707
+12% +$761K 0.03% 423
2025
Q3
$6.69M Sell
83,708
-7,303
-8% -$623K 0.03% 470
2025
Q2
$8.16M Sell
91,011
-1,901
-2% -$174K 0.03% 392
2025
Q1
$8.7M Buy
92,912
+1,686
+2% +$151K 0.04% 383
2024
Q4
$8.29M Buy
91,226
+2,069
+2% +$197K 0.04% 377
2024
Q3
$9.26M Sell
89,157
-85
-0.1% -$8.66K 0.04% 353
2024
Q2
$8.66M Sell
89,242
-2,693
-3% -$248K 0.04% 346
2024
Q1
$8.28M Buy
91,935
+515
+0.6% +$43.6K 0.04% 359
2023
Q4
$7.34M Buy
+91,420
New +$6.87M 0.04% 329

Other funds holding CL

Pathstone Holdings's CL Position: Q2 2026 in Review

Pathstone Holdings reduced its Colgate-Palmolive (CL) stake by 0.99% in Q2 2026, selling an estimated $79K and leaving 90,011 shares worth $8.28M. The position accounts for 0.02% of the portfolio, ranked #475.

Pathstone Holdings first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.26M in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Pathstone Holdings held 90,011 shares of Colgate-Palmolive worth $8.28M as of Q2 2026.
  • Pathstone Holdings sold 903 Colgate-Palmolive shares in Q2 2026, an estimated $79K.
  • Colgate-Palmolive made up 0.02% of Pathstone Holdings's portfolio in Q2 2026, its #475 holding.
  • Pathstone Holdings first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Colgate-Palmolive position peaked at $9.26M in Q3 2024.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.